Optimization of culture conditions for rapid clinical‐scale expansion of human umbilical cord blood‐derived mesenchymal stem cells
Open Access
- 10 October 2017
- journal article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 6 (1), 38
- https://doi.org/10.1186/s40169-017-0168-z
Abstract
Background Mesenchymal stem cells (MSCs) have broad‐spectrum therapeutic effects in various diseases, and thus have many clinical applications. However, it is difficult to produce sufficient numbers of MSCs for clinical use, and improved culture systems are required. Here, we report the effects of calcium (Ca2+) and hypoxia on the proliferation of human umbilical cord blood‐derived MSCs (hUCB‐MSCs). In addition, we determined the optimal conditions of these two factors for the large‐scale culture of hUCB‐MSCs. Methods hUCB‐MSCs were maintained under hypoxic conditions (3% O2) with 1.8 mM Ca2+ during long‐term culture, and their proliferation was evaluated. To characterize the underlying mechanisms, the effects on hypoxia‐inducible factor (HIF)‐1α and the extracellular signal‐regulated kinase (ERK) signaling pathways were investigated. The therapeutic effects in a mouse emphysema model were analyzed and compared with those of naive MSCs. Results The proliferation of Ca2+/hypoxia‐treated hUCB‐MSCs was increased compared with that observed using either calcium or hypoxia culture alone, without loss of stem cell marker expression or differentiation ability. The enhancement of the proliferation capacity of hUCB‐MSCs by the synergistic effects of Ca2+ and hypoxia was dependent on the expression of HIF‐1α and the ERK signaling pathway. The proliferation of Ca2+/hypoxia‐treated hUCB‐MSCs resulted in a delayed senescence phenotype and increased the expression levels of stemness genes such as Oct4 and Nanog compared to those observed in conventional culture conditions. In addition, Ca2+/hypoxia‐treated MSCs transplantation in the mouse emphysema model showed the same therapeutic effects as observed with naive MSCs. Conclusions These findings suggest that a Ca2+/hypoxia‐based expansion system has applications for the large‐scale production of MSCs for therapeutic purposes.Keywords
This publication has 35 references indexed in Scilit:
- Effects of Severe Hypoxia on Bone Marrow Mesenchymal Stem Cells Differentiation PotentialStem Cells International, 2013
- Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Umbilical Cord Blood as Sources of Cell TherapyInternational Journal of Molecular Sciences, 2013
- Low Oxygen Tension Maintains Multipotency, Whereas Normoxia Increases Differentiation of Mouse Bone Marrow Stromal CellsInternational Journal of Molecular Sciences, 2013
- Hypoxia improves expansion potential of human cord blood–derived hematopoietic stem cells and marrow repopulation efficiencyEuropean Journal of Haematology, 2012
- Toward a Clinical-Grade Expansion of Mesenchymal Stem Cells from Human Sources: A Microcarrier-Based Culture System Under Xeno-Free ConditionsTissue Engineering, Part C: Methods, 2011
- Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-β plaquesCell Death & Differentiation, 2011
- CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomasBiochemical and Biophysical Research Communications, 2011
- Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cellsCell Communication and Signaling, 2010
- DNA methylation pattern changes upon long‐term culture and aging of human mesenchymal stromal cellsAging Cell, 2010
- Calcium Induces Cell Survival and Proliferation through the Activation of the MAPK Pathway in a Human Hormone-dependent Leukemia Cell Line, TF-1Published by Elsevier BV ,2003